KORU Medical Systems Inc (KRMD)

NASD · Healthcare · Medical Instruments & Supplies · USA

KORU Medical Systems Inc is a micro cap company (market value under $300 million) in the Medical Instruments & Supplies industry.

KORU Medical develops and manufactures the FREEDOM System, a mechanical infusion platform comprising syringe drivers, needle sets, and tubing for subcutaneous drug delivery. Revenue comes from domestic and international product sales for immunodeficiency and neuropathy treatment, plus pharmaceutical services including clinical trials and device customization. Products distribute through specialty pharmacies and home infusion providers.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the KORU Medical Systems Inc stock.

Our verdict on KRMD

Overvalued: intrinsic value $0.20 per share, market price $3.49, margin of safety -1613.1% (as of 2026-11-17).

Its liquidation floor, current assets minus every liability, values the shares at $0.20; the price of $3.49 is 1613% above that value.

ETFs with the most weight in KRMD

12 more funds hold it; the full list is part of the paid plan.

More on KRMD

Browse

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Cheaper than KRMD in Medical Instruments & Supplies

22 more in this industry show a wider margin of safety.

Is KRMD undervalued or overvalued?

KRMD is overvalued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $0.20; the price of $3.49 is 1613% above that value.

What is the intrinsic value of KRMD?

$0.20 per share (as of the 2026-11-17 close), against a market price of $3.49. That is a margin of safety of -1613.1%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.